Calcium and Colecalciferol
|
|
|
- Melina Edwards
- 9 years ago
- Views:
Transcription
1 PACKAGE LEAFLET: INFORMATION FOR THE USER <Calcium 1000 mg / Vitamin D IU, chewable tablets> Calcium and Colecalciferol Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still need to take <Calcium 1000 mg / Vitamin D IU, chewable tablets> carefully to get the best results from it. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - You must contact a doctor if your symptoms worsen or do not improve. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What <Calcium 1000 mg / Vitamin D IU, chewable tablets> is and what it is used for 2. Before you take <Calcium 1000 mg / Vitamin D IU, chewable tablets> 3. How to take <Calcium 1000 mg / Vitamin D IU, chewable tablets> 4. Possible side effects 5. How to store <Calcium 1000 mg / Vitamin D IU, chewable tablets> 6. Further information 1. WHAT <CALCIUM 1000 MG / VITAMIN D IU, CHEWABLE TABLETS> IS AND WHAT IT IS USED FOR <Calcium 1000 mg / Vitamin D IU, chewable tablets> is a calcium-vitamin D 3-supplement. It is used - to prevent and treat a lack of calcium and vitamin D in the elderly. - for vitamin D- and calcium supplementation as supportive treatment of osteoporosis (brittle bones). 2. BEFORE YOU TAKE <CALCIUM 1000 MG / VITAMIN D IU, CHEWABLE TABLETS> Do not take <Calcium 1000 mg / Vitamin D IU, chewable tablets> - if you are allergic (hypersensitive) to calcium, vitamin D 3 or any of the other ingredients of <Calcium 1000 mg / Vitamin D IU, chewable tablets> - if you have high levels of calcium in your blood (hypercalcaemia) - if you have increased excretion of calcium with your urine (hypercalciuria) - if you suffer from overactive parathyroid glands (hyperparathyroidism) - if you suffer from bone marrow cancer (myeloma) - if you suffer from cancer that has affected your bones (bone metastases). - if you have a restraint of the limbs (prolonged immobilisation) accompanied with hypercalcaemia and / or hypercalciuria - if you have kidney stones (nephrolithiasis) - if you have calcium deposits in your kidneys (nephrocalcinosis) 1
2 - if you suffer from an excessive supply of vitamin D (hypervitaminosis D) - if you have severe kidney problems Take special care with <Calcium 1000 mg / Vitamin D IU, chewable tablets> - during long-term treatment the levels of calcium in your blood and urine and your kidney function have to be monitored regularly. This is especially important if you have a tendency to develop kidney stones. Depending on your blood levels your doctor might reduce the dosage or discontinue the treatment. - if you are simultaneously being treated with cardiac glycosides or thiazide diuretics (water tablets) for heart problems the levels of calcium in your blood and urine and your kidney function have to be monitored regularly. Depending on your blood levels your doctor might reduce the dosage or discontinue the treatment. - if you suffer from kidney problems you have to take <Calcium 1000 mg / Vitamin D IU, chewable tablets> with special care. Your calcium levels of the blood and urine have to be checked. If you suffer from severe kidney problems, use other forms of vitamin D than cholecalciferol. - Take additional supplementation of calcium and vitamin D only under medical supervision and your doctor will require frequent monitoring of the calcium levels in the blood and urine. - Take special care when taking <Calcium 1000 mg / Vitamin D IU, chewable tablets> if you suffer from sarcoidosis (an immune system disorder which may affect your liver, lung, skin or lymph nodes). There is a risk that the effect of this medicinal product gets too strong which can result in an overdose of calcium in the body. The levels of calcium in the blood and urine have to be monitored. - if you are immobile and are suffering from osteoporosis this medicinal product has to be used with special care, as the level of calcium in your blood might increase. <Calcium 1000 mg / Vitamin D IU, chewable tablets> are not intended for use in children and adolescents. Taking other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. - In the case of simultaneous treatment with digitalis glycosides (cardiac glycosides derived from foxglove), cardiac arrhythmias can occur. Rigorous medical monitoring including an ECG and measurement of the blood calcium level is therefore necessary. - In the case of simultaneous administration of diuretics of the thiazide drug class (also called water tablets), the blood calcium level should be regularly monitored since thiazides decrease the excretion of calcium in the urine. - The absorption and thus also the effectiveness of certain antibiotics (called tetracyclines) are decreased by the simultaneous administration of <Calcium 1000 mg / Vitamin D IU, chewable tablets>. These drugs should be taken at least 2 hours before or 4-6 hours after <Calcium 1000 mg / Vitamin D IU, chewable tablets>. - Furthermore, other medicines such as sodium fluoride (used to strengthen the tooth enamel or to treat osteoporosis) and bisphosphonate (used to treat osteoporosis) drugs are affected by interactions. These products should therefore be taken at least 3 hours before <Calcium 1000 mg / Vitamin D IU, chewable tablets>. - As long an interval as possible should be left between the administration of cholestyramine (a product to lower raised cholesterol levels) or laxatives such as liquid paraffin and <Calcium 1000 mg / Vitamin D IU, chewable tablets> since otherwise vitamin D is not absorbed properly. - The simultaneous administration of <Calcium 1000 mg / Vitamin D IU, chewable tablets> and phenytoin (a product for the treatment of epilepsy) or barbiturates (hypnotics) can result in a reduction in the effect of vitamin D. - The simultaneous administration of <Calcium 1000 mg / Vitamin D IU, chewable tablets> and glucocorticoids (e. g. cortisone) can result in a reduction in the effect of vitamin D and to a decreased calcium level in the blood. - The additional supplementation of calcium and vitamin D should be given only under medical supervision and will require frequent monitoring of the calcium levels in the blood and urine. 2
3 - Calcium can reduce the effect of levothyroxine (used to treat thyroid deficiency). For this reason, levothyroxine should be taken at least four hours before or four hours after <Calcium 1000 mg / Vitamin D IU, chewable tablets>. - The effect of quinolone antibiotics may be reduced if taken at the same time as calcium. Take quinolone antibiotics two hours before or six hours after taking <Calcium 1000 mg / Vitamin D IU, chewable tablets>. - Calcium salts may decrease the absorption of iron, zinc and strontium ranelate. Consequently iron, zinc or strontium ranelate preparations should be taken at least two hours before or after <Calcium 1000 mg / Vitamin D IU, chewable tablets>. Taking <Calcium 1000 mg / Vitamin D IU, chewable tablets> with food and drink You can take <Calcium 1000 mg / Vitamin D IU, chewable tablets> at any time, with or without food. Please notice that oxalic acid (contained in spinach and rhubarb) and phytic acid (contained in wholegrain cereals) can reduce the amount of calcium you absorb in your bowel. In the 2 hours before or after eating food containing high amounts of oxalic or phytic acid patients should not take medicinal products that contain calcium. Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. If you are pregnant you may use <Calcium 1000 mg / Vitamin D IU, chewable tablets> in case of a calcium and vitamin D deficiency. The daily dose of half a tablet must not be exceeded. During pregnancy the total daily amount of calcium should not be higher than 1,500 mg and the total daily amount of vitamin D 3 should not be higher than 600 IU (International Units). Long-term overdose of calcium and vitamin D during pregnancy must be avoided since this may lead to high levels of calcium in the blood and may have a negative effect on the unborn child. <Calcium 1000 mg / Vitamin D IU, chewable tablets> can be used during breast-feeding. As calcium and vitamin D pass into breast-milk check with your doctor first if your child receives any other products containing vitamin D. Driving and using machines <Calcium 1000 mg / Vitamin D IU, chewable tablets> has no influence on your ability to drive and use machines. Important information about some of the ingredients of <Calcium 1000 mg / Vitamin D IU, chewable tablets> This medicine contains aspartame (E951), a source of phenylalanine which may be harmful for people with phenylketonuria. This medicine also contains sorbitol (E420), isomalt (E953) and sucrose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. 3. HOW TO TAKE <CALCIUM 1000 MG / VITAMIN D IU, CHEWABLE TABLETS> Always take <Calcium 1000 mg / Vitamin D IU, chewable tablets> exactly as your doctor or pharmacist has told you. You should check with your doctor or pharmacist if you are not sure. Always take <Calcium 1000 mg / Vitamin D IU, chewable tablets> exactly as described in this leaflet. You should check with your doctor or pharmacist if you are not sure. Dosage If not told otherwise by your doctor the usual dose is: 3
4 Adults and elderly take 1 chewable tablet daily (corresponding to 1,000 mg of calcium and 880 IU (International Units) of vitamin D 3). Pregnant women take only half a chewable tablet daily (corresponding to 500 mg of calcium and 440 IU (International Units) of vitamin D 3). The daily dose of half a tablet must not be exceeded. Method of administration The tablet has to be chewed before it is swallowed. It should be taken at any time, with or without food. Duration of treatment <Calcium 1000 mg / Vitamin D IU, chewable tablets> should be taken as long-term treatment. Talk to your doctor how long you should take <Calcium 1000 mg / Vitamin D IU, chewable tablets> (see also section 2, Take special care with <Calcium 1000 mg / Vitamin D IU, chewable tablets>). If you take more <Calcium 1000 mg / Vitamin D IU, chewable tablets> than you should Overdose of <Calcium 1000 mg / Vitamin D IU, chewable tablets> may lead to symptoms such as feeling sick (nausea), vomiting, excessive thirst, increased urine output, depletion of body fluids or constipation, abdominal pain, muscle weakness, tiredness, mental disturbances, lack of appetite, bone pain, kidney problems and, in severe cases, irregular heartbeat. Very rarely in addition: irritability, continuing headache, lightheadedness, muscle spasms, twitches and tingling sensation. If an overdose is suspected, contact your doctor or pharmacist immediately. If you forget to take <Calcium 1000 mg / Vitamin D IU, chewable tablets> If you forget to take <Calcium 1000 mg / Vitamin D IU, chewable tablets>, take it as soon as you remember. However, do not take a double dose to make up for a forgotten tablet. If you stop taking <Calcium 1000 mg / Vitamin D IU, chewable tablets> If you wish to interrupt or prematurely discontinue the treatment, please consult your doctor. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, <Calcium 1000 mg / Vitamin D IU, chewable tablets> can cause side effects, although not everybody gets them. The evaluation of side effects is based on the following frequencies: very common: affects more than 1 user in 10 Common: affects 1 to 10 users in 100 Uncommon: affects 1 to 10 users in 1,000 Rare: affects 1 to 10 users in 10,000 Very rare: affects less than 1 user in 10,000 Not known: frequency cannot be estimated from the available data Stop taking <Calcium 1000 mg / Vitamin D IU, chewable tablets> and contact a doctor immediately if you experience the following possible adverse reactions: Rare side effects: - feeling sick (nausea), diarrhoea, abdominal pain, constipation, wind (flatulence), bloating (abdominal distension), stomach ache. - rash, itching, hives. 4
5 Uncommon side effects: - high levels of calcium in your blood (hypercalcaemia: a high blood calcium level, with potential symptoms of excessive thirst, nausea, vomiting, lack of appetite, constipation, stomache ache, bone pain, a need to pass more water than usual, muscle weakness, drowsiness, confusion, fatique and in severe cases irregular heart beat) or urine (hypercalciuria). Very rare side-effects: - Milk alkali syndrome (usually only seen in overdose see if you take more than you should ) Frequency not known: - Hypersensitivity reactions such as swelling of the face, tongue, lips (angioedema) or swelling of the throat (laryngeal oedema) with sudden difficulty breathing and severe rash. - If you have impaired renal function, you may be at risk of increased amounts of phosphate in the blood, renal stone formation and increased amounts of calcium in the kidneys. Reporting of side effects If you get any side effects, talk to your <doctor> <or> <,> <pharmacist> <or nurse>. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V*. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE <CALCIUM 1000 MG / VITAMIN D IU, CHEWABLE TABLETS> Keep out of the reach and sight of children. Do not use <Calcium 1000 mg / Vitamin D IU, chewable tablets> after the expiry date (EXP) which is stated on the carton and on the tablet container or on the laminated aluminium paper foil. The expiry date (EXP) refers to the last day of that month. For tablet container: Keep the tablet container tightly closed in order to protect from moisture. For strips: This medicinal product does not require any special storage conditions. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What <Calcium 1000 mg / Vitamin D IU, chewable tablets> contains - The active substances are calcium and colecalciferol. Each chewable tablet contains 2,500 mg of calcium carbonate (equivalent to 1,000 mg of calcium) and 8.8 mg of colecalciferol concentrate (powder form) (equivalent to 22 micrograms of colecalciferol = 880 IU of vitamin D 3). - The other ingredients are isomalt (E953), xylitol, sorbitol (E420), citric acid, anhydrous, sodium dihydrogen citrate, magnesium stearate, carmellose sodium, flavour orange CPB and flavour orange CVT (which both contain sorbitol (E420)), aspartame (E951), acesulfam potassium, sodium ascorbate, all-rac-alpha-tocopherol, modified (maize) starch, sucrose, triglycerides medium chain and silicon dioxide colloidal. What <Calcium 1000 mg / Vitamin D IU, chewable tablets> looks like and contents of the pack <Calcium 1000 mg / Vitamin D IU, chewable tablets> are round, white tablets with faultless surface and a breakmark. The tablet can be divided into equal halves. The chewable tablets are available in polypropylene tablet containers with polyethylene stoppers containing a desiccant in the following package sizes: DE/H/2857/001/DC: 10, 20, 30, 40, 50, 60, 90, 100 (bundling package 5x20) chewable tablets 5
6 DE/H/2858/001/DC: 1 or 3 tablet containers of 30 chewable tablets DE/H/2859/001/DC: 10, 20, 30, 40, 50, 60, 90, 100 (bundling package 5x20) chewable tablets DE/H/2860/001/DC: 10, 20, 28, 30, 40, 50, 56, 60, 90, 100 (bundling package 5x20) chewable tablets DE/H/2924/001/DC: 10, 20, 30, 40, 50, 60, 90, 100 (bundling package 5x20) chewable tablets DE/H/2925/001/DC: 20, 28, 30, 50, 56, 60, 90, 100 (bundling package 5x20) chewable tablets The chewable tablets are available in strips of laminated aluminium paper foil in the following package sizes: DE/H/2856/001/DC: 10, 20, 30, 40, 48, 60, 60 (bundling package 2x30), 90, 90 (bundling package 3x30), 96, 100 (bundling package 5x20) chewable tablets DE/H/2857/001/DC: 10, 20, 30, 40, 48, 60, 60 (bundling package 2x30), 90, 90 (bundling package 3x30), 96, 100 (bundling package 5x20) chewable tablets DE/H/2858/001/DC: 30, 90 chewable tablets DE/H/2859/001/DC: 10, 20, 30, 40, 48, 60, 60 (bundling package 2x30), 90, 90 (bundling package 3x30), (bundling package 5x20) chewable tablets DE/H/2860/001/DC: 10, 20, 28, 30, 40, 48, 56, 60, 60 (bundling package 2x30), 90, 90 (bundling package 3x30), 96, 100 (bundling package 5x20) chewable tablets DE/H/2924/001/DC: 10, 20, 30, 40, 48, 60, 60 (bundling package 2x30), 90, 90 (bundling package 3x30), 96, 100 (bundling package 5x20) chewable tablets DE/H/2925/001/DC: 20, 28, 30, 48, 56, 60, 90, 96, 100 (bundling package 5x20) chewable tablets Not all pack sizes may be marketed. Marketing Authorisation Holder [To be completed nationally] {Name and address} {tel} {fax} { } Manufacturer Hermes Arzneimittel GmbH Georg-Kalb-Straße Großhesselohe / Munich Germany This medicinal product is authorised in the Member States of the EEA under the following names: [To be completed in the final PL] This leaflet was last approved in {MM/YYYY}. [To be completed nationally] 6
(NON-PRESCRIPTION) LEAFLET: USER INFORMATION. CALTRATE VITAMIN D3 600mg/400 IU, film-coated tablet Calcium and Cholecalciferol
(NON-PRESCRIPTION) LEAFLET: USER INFORMATION CALTRATE VITAMIN D3 600mg/400 IU, film-coated tablet Calcium and Cholecalciferol Read all of this leaflet carefully because it contains important information
Package leaflet: Information for the patient. Cholecalciferol mibe 500 IE, tabletten Cholecalciferol. For use in infants, children and adults
Package leaflet: Information for the patient Cholecalciferol mibe 500 IE, tabletten Cholecalciferol For use in infants, children and adults Read all of this leaflet carefully before you start taking this
Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you.
leaflet: Information for the user Macrogol 4000 10 g powder for oral solution in sachet Macrogol 4000
MRP-No. DE/H/0279/001/P/002 Dr. Scheffler Vitamin C, 1000mg, effervescent tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Dr. Scheffler Vitamin C, 1000 mg, effervescent tablets Ascorbic Acid Read all of this leaflet carefully because it contains important information for you. This
PATIENT INFORMATION LEAFLET. Calcium Sandoz Syrup calcium glubionate and calcium lactobionate
PATIENT INFORMATION LEAFLET Calcium Sandoz Syrup calcium glubionate and calcium lactobionate Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to
There is a risk of renal impairment in dehydrated children and adolescents.
PACKAGE LEAFLET: INFORMATION FOR THE USER MELFEN 200mg FILM-COATED TABLETS MELFEN 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking this medicine because it
Package leaflet: Information for the patient. Laxido Orange, powder for oral solution
Package leaflet: Information for the patient Laxido Orange, powder for oral solution Read all of this leaflet carefully before you start taking this medicine because it contains important information for
PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER PFIZER Dalacin C 150 mg Capsules clindamycin hydrochloride Dalacin C 150mg Capsules clindamycin hydrochloride PFIZER Read all of this leaflet carefully before
PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN
PATIENT INFORMATION LEAFLET CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again.
Irish Medicines Board
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. No.540 of 2007) PA0030/038/001 Case No: 2075491 The Irish Medicines Board in exercise
PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol 500 mg Effervescent Tablets Paracetamol
PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol 500 mg Effervescent Tablets Paracetamol Read all of this leaflet carefully because it contains important information for you. This medicine is available
Package leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate
Package leaflet: Information for the patient Bricanyl Tablets 5 mg terbutaline sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important information
PACKAGE LEAFLET: INFORMATION FOR THE USER. /.../ 2.5 mg orodispersible tablets. Desloratadine
PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER /.../ 2.5 mg orodispersible tablets Desloratadine Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.
Share the important information in this Medication Guide with members of your household.
MEDICATION GUIDE BUPRENORPHINE (BUE-pre-NOR-feen) Sublingual Tablets, CIII IMPORTANT: Keep buprenorphine sublingual tablets in a secure place away from children. Accidental use by a child is a medical
Package leaflet: Information for the user. Ondemet 4mg and 8mg Tablets (Ondansetron)
Package leaflet: Information for the user Ondemet 4mg and 8mg Tablets (Ondansetron) Read all of this leaflet carefully before you start taking this medicine because it contains important information for
Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid
Package Leaflet: Information for the User Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid For use in adults Active substance: Alpha-lipoic acid, Trometamol salt (1:1) Read all
PATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET CHLORDIAZEPOXIDE 5mg AND 10mg CAPSULES Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you have
PATIENT INFORMATION LEAFLET. Forceval Junior Capsules
PATIENT INFORMATION LEAFLET Forceval Junior Capsules Read all of this leaflet carefully because it contains important information for you or your child. Please note this leaflet has been written as if
MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)
MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b) Read this Medication Guide before you start taking SYLATRON, and each time you get a refill. There may be new information. This Medication
Prochlorperazine 3 mg Buccal Tablets (PROCHLORPERAZINE MALEATE)
Package leaflet: Information for the user Prochlorperazine 3 mg Buccal Tablets (PROCHLORPERAZINE MALEATE) Read all of this leaflet carefully before you start taking this medicine because it contains important
Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules
Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication Guide before you start taking Tasigna and each time you get a refill. There may be new information. This information does
PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin 500 mg film-coated tablets Metformin 850 mg film-coated tablets. Metformin hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Metformin 500 mg film-coated tablets Metformin 850 mg film-coated tablets Metformin hydrochloride Read all of this leaflet carefully before you start taking this
Tradol SR 100mg Prolonged Release Tablets Tramadol hydrochloride
Package leaflet: Information for the user Tradol SR 100mg Prolonged Release Tablets Tramadol hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important
2 What you need to know before you have Ampiclox
Reason for update: GDS 14 & QRD Updates Response to questions for variation update section 4.1 of SPC MHRA Submission Date: 6 November 2014 MHRA Approval Date: Text Date: October 2014 Text Issue and Draft
PATIENT INFORMATION LEAFLET. Forceval Capsules
PATIENT INFORMATION LEAFLET Forceval Capsules Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still need
DULCOLAX Tablets and Suppositories Bisacodyl
New Zealand Consumer Medicine Information DULCOLAX Tablets and Suppositories Bisacodyl What is in this leaflet This leaflet answers some common questions about DULCOLAX. It does not contain all available
PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)
PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride) This medicine is for use in men only Read all of this leaflet carefully before you start to take this medicine.
JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets
JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets What is in this leaflet This leaflet answers some common questions about JANUVIA. It does not contain all the available information. It does
Patient Medication Guide Brochure
Patient Medication Guide Brochure 1 MEDICATION GUIDE TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication Guide before you start taking TASIGNA and each time you get a refill. There may be new
MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets
MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets Read this Medication Guide carefully before you start taking KOMBIGLYZE XR and each time you get
Read all of this leaflet carefully before you start taking this medicine
LAX-SACHETS 13.72g sachet, powder for oral solution Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to read it again. If you have any further questions,
MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)
MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental
Package Leaflet: Information for the user. <Levetiracetam 750 mg, film-coated tablets> <Levetiracetam 1000 mg, film-coated tablets> Levetiracetam
Package Leaflet: Information for the user
1.3.1.3 PACKAGE LEAFLET
Sandoz Business use only Page 1 of 8 1.3.1.3 PACKAGE LEAFLET Sandoz Business use only Page 2 of 8 Package leaflet: Information for the patient Cefuhexal 250 mg film-coated tablets Cefuhexal 500 mg film-coated
Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules
Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules Read this Medication Guide before you start taking EQUETRO and each time you get a refill. There may be new information. This
[For POM]: Read all of this leaflet carefully before you start using this medicine.
Package Leaflet: Information for the User Duraphat 500mg/100g Toothpaste Active Substance: Sodium Fluoride [For POM]: Read all of this leaflet carefully before you start using this medicine. - Keep this
PACKAGE LEAFLET: INFORMATION FOR THE USER. METFORMINE MYLAN 850 mg dispersible tablets metformin hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER METFORMINE MYLAN 850 mg dispersible tablets metformin hydrochloride Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.
MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including:
MEDGUIDE SECTION Medication Guide SEROQUEL (SER-oh-kwell) (quetiapine fumarate) Tablets Read this Medication Guide before you start taking SEROQUEL and each time you get a refill. There may be new information.
PATIENT INFORMATION LEAFLET: CENTRUM. Read the contents of this leaflet carefully before you start using CENTRUM, because it
PATIENT INFORMATION LEAFLET: CENTRUM Page 1 of 7 This leaflet tells you about CENTRUM tablets. Read the contents of this leaflet carefully before you start using CENTRUM, because it contains important
IMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION FOSAVANCE 70/2800 (alendronate sodium/cholecalciferol) Once Weekly Tablets 70 mg alendronate + 70 mcg cholecalciferol (2800 IU vitamin D 3 ) FOSAVANCE 70/5600 (alendronate
Amlodipine 5 and 10 mg tablets
Package leaflet: Information for the patient Amlodipine Apotex 5 mg tablets Amlodipine Apotex 10 mg tablets Amlodipine besilate Read all of this leaflet carefully before you start taking this medicine
PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin
PACKAGE LEAFLET: INFORMATION FOR THE USER VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution Cyanocobalamin Read all of this leaflet carefully before you start using this medicine because
Restandol Testocaps, 40mg CAPSULES, SOFT Testosterone undecanoate
RA 1410 IE P7 (ref 3.5) PATIENT INFORMATION LEAFLET Restandol Testocaps, 40mg CAPSULES, SOFT Testosterone undecanoate Read all of this leaflet carefully before you start taking this medicine. Keep this
PACKAGE LEAFLET Page 1 of 7
PACKAGE LEAFLET Page 1 of 7 Package leaflet: information for the user Bisoprolol fumarate 1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 7.5 mg or 10 mg film-coated tablets (bisoprolol fumarate) Read all of this leaflet
Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride
Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride This medicine is for use in men only Read all of this leaflet carefully before you start taking this medicine because
Package leaflet: Information for the user. Maxtrex 2.5mg Tablets methotrexate
Package leaflet: Information for the user Maxtrex 2.5mg Tablets methotrexate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride)
Package leaflet: Information for the patient Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride) Read all of this leaflet carefully before you start taking this medicine because it
Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets
Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets Read this Patient Information carefully before you start taking VYTORIN and each time you get a refill. There may be new information.
CONSUMER MEDICINE INFORMATION ARROW - ROXITHROMYCIN
CONSUMER MEDICINE INFORMATION ARROW - ROXITHROMYCIN Roxithromycin 150 mg and 300 mg tablets What is in this leaflet This leaflet answers some common questions about ARROW - ROXITHROMYCIN. It does not contain
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] mepolizumab lyophilized powder for subcutaneous injection Read this carefully before you start
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. sacubitril/valsartan film-coated tablets
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr ENTRESTO TM sacubitril/valsartan film-coated tablets Read this carefully before you start taking ENTRESTO TM and
Patient Information Once Weekly FOSAMAX (FOSS-ah-max) (alendronate sodium) Tablets and Oral Solution
Patient Information Once Weekly FOSAMAX (FOSS-ah-max) (alendronate sodium) Tablets and Oral Solution Read this information before you start taking FOSAMAX *. Also, read the leaflet each time you refill
PACKAGE LEAFLET: INFORMATION FOR THE USER. Methotrexate 2.5 mg Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Methotrexate 2.5 mg Tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this
MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets
MEDICATION GUIDE (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets Read this Medication Guide carefully before you start taking and each time you get a refill. There may
Rubifen SR 20 mg slow release tablets
Rubifen 10 mg immediate release tablets Rubifen SR 20 mg slow release tablets methylphenidate hydrochloride What is in this leaflet This leaflet answers some common questions about Rubifen. It does not
Motilium 1mg/ml Oral Suspension Domperidone
Motilium 1mg/ml Oral Suspension Domperidone PACKAGE LEAFLET: INFORMATION FOR THE USER Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read
MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?
MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules What is the most important information I should know about POMALYST? Before you begin taking POMALYST, you must read and agree to all of
New Zealand Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.
New Zealand Consumer Medicine Information Antabuse Disulfiram 200mg tablets (die-sul-fear-am) What is in this leaflet? This leaflet answers some common questions about Antabuse. It does not contain all
Take special care with Septrin Taking other medicines Taking Septrin with food and drink
Aspen Logo Package Leaflet: Information for the User Septrin 160 mg/800 mg Forte Tablets co-trimoxazole Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may
N HUMAN Novo Nordisk Patient Information for Novolin N
N HUMAN Novo Nordisk Patient Information for Novolin N NOVOLIN N (NO-voe-lin) NPH, Human Insulin Isophane Suspension Injection (recombinant DNA origin) 100 units/ml Important: Know your insulin. Do not
PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate) Read all of this leaflet carefully before you start taking this medicine because
Prednisolone 2.5mg tablets (enteric-coated)
Due to technical difficulties in printing the label-leaflet format, please find the relevant text below. Text is representative of the leaflet portion of label-leaflet spec no 50329461. Prednisolone 2.5mg
Vibramycin Capsules Doxycycline hyclate capsules USP. Vibra-Tabs Film Coated Tablets Doxycycline hyclate tablets USP
32 READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Vibramycin Capsules Doxycycline hyclate capsules USP Vibra-Tabs Film Coated Tablets Doxycycline hyclate tablets USP
Public Assessment Report. UK National Procedure. (colecalciferol) PL 16508/0047 PL 16508/0048. ProStrakan Ltd.
Public Assessment Report UK National Procedure STEXEROL-D 3 1,000 IU FILM-COATED TABLETS STEXEROL-D 3 25,000 IU FILM-COATED TABLETS (colecalciferol) PL 16508/0047 PL 16508/0048 ProStrakan Ltd. 1 LAY SUMMARY
Package leaflet: Information for the user
Package leaflet: Information for the user Olanzapine Actavis 5 mg orodispersible tablet Olanzapine Actavis 10 mg orodispersible tablet Olanzapine Actavis 15 mg orodispersible tablet Olanzapine Actavis
For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only OR for Specialist Use only
For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only OR for Specialist Use only Cholecalciferol Granules VITOMIN D3 COMPOSITION Each sachet of 1 g contains: Cholecalciferol
NEW ZEALAND CONSUMER MEDICINE INFORMATION Arrow - Diazepam
NEW ZEALAND CONSUMER MEDICINE INFORMATION Arrow - Diazepam Diazepam 2mg and 5mg tablets What is in this leaflet This leaflet answers some common questions about ARROW - DIAZEPAM. It does not contain all
1 What Anapen is and what it is used for?
PACKAGE LEAFLET: INFORMATION FOR THE USER Anapen 500 micrograms in 0.3 ml solution for injection (pre-filled syringe) Adrenaline (Epinephrine) Auto-Injector Read all of this leaflet carefully before you
What Codeine Phosphate Tablets are used for
New Zealand Consumer Medicine Information CODEINE PHOSPHATE 15mg, 30mg & 60mg Tablets What is in this leaflet Please read this leaflet carefully before you start using Codeine Phosphate Tablets. This leaflet
Package leaflet: Information for the patient
Package leaflet: Information for the patient Metformin Teva 500 mg Film-coated Tablets Metformin Teva 850 mg Film-coated Tablets metformin hydrochloride Read all of this leaflet carefully before you start
IMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION Pr CHAMPI (varenicline tartrate tablets) Read this information each time you refill your prescription in case new information has been added. This leaflet is part III of
2. What you need to know before you take Restandol Testocaps
RESTANDOL TESTOCAPS TM 40MG CAPSULES, SOFT Testosterone undecanoate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this
Package leaflet: Information for the user Naltrexone Hydrochloride 50 mg film-coated tablets Naltrexone Hydrochloride
Package leaflet: Information for the user Naltrexone Hydrochloride 50 mg film-coated tablets Naltrexone Hydrochloride Read all of this leaflet carefully before you start taking this medicine because it
SYNACTHEN i.m./i.v. tetracosactide hexaacetate
New Zealand Consumer Medicine Information SYNACTHEN i.m./i.v. tetracosactide hexaacetate 250 micrograms/ml solution for injection or infusion What is in this leaflet This leaflet answers some common questions
Zomig Nasal Spray. Zolmitriptan 5 mg Nasal Spray Solution. CONSUMER MEDICINE INFORMATION
Zomig Nasal Spray Zolmitriptan 5 mg Nasal Spray Solution. CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some of the common questions people ask about It does not contain all
Galvumet Vildagliptin/Metformin hydrochloride Consumer Medicine Information
Galvumet Vildagliptin/Metformin hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Galvumet. It does not contain all the available information.
PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol
PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.
Early Access to Medicines Scheme Treatment protocol Information for patients
Early Access to Medicines Scheme Treatment protocol Information for patients Introduction The aim of the Early Access to Medicines Scheme (EAMS) is to provide earlier availability of promising new unlicensed
MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets
MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets Read this Medication Guide carefully before you start using WELLBUTRIN and each time you get a refill. There may be new information.
1. What Xylocaine with adrenaline is and what it is used for
Package leaflet: Information for the user Xylocaine 1% and 2% with adrenaline (epinephrine) 1:200,000 Solution for Injection lidocaine, adrenaline (epinephrine) Read all of this leaflet carefully before
1. What Olanzapine Tablets is and what it is used for
PACKAGE LEAFLET: INFORMATION FOR THE USER Olanzapine 2.5 mg Film-coated Tablets Olanzapine 5 mg Film-coated Tablets Olanzapine 7.5 mg Film-coated Tablets Olanzapine 10 mg Film-coated Tablets Olanzapine
Medication Guide. Serious loss of body fluid (dehydration) and changes in blood salts (electrolytes) in your blood.
Medication Guide MoviPrep (moo-vee-prěp) (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution) Read this Medication Guide before you start
Testosterone propionate, phenylpropionate, isocaproate and decanoate. Please read this leaflet carefully before you start using SUSTANON 250.
SUSTANON 250 Testosterone propionate, phenylpropionate, isocaproate and decanoate What is in this leaflet Please read this leaflet carefully before you start using SUSTANON 250. This leaflet answers some
This leaflet answers some common questions about ARROW - MELOXICAM.
Arrow - Meloxicam Meloxicam Tablets 7.5mg What is in this leaflet This leaflet answers some common questions about ARROW - MELOXICAM. It does not contain all of the available information. It does not take
MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets
MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets Savella is not used to treat depression, but it acts like medicines that are used to treat depression (antidepressants) and other psychiatric
What is in this leaflet. 3. How to take Zimovane 4. Possible side effects 5. How to store Zimovane 6. Contents of the pack and other information
PACKAGE LEAFLET: INFORMATION FOR THE USER Zimovane 7.5 mg film-coated tablets Zimovane LS 3.75 mg film-coated tablets zopiclone Is this leaflet hard to see or read? Phone 08453727101 for help Read all
PHARMACIST DETACH HERE AND GIVE TO PATIENT
PHARMACIST DETACH HERE AND GIVE TO PATIENT MEDICATION GUIDE HORIZANT (ho-ri' zant) (gabapentin enacarbil) Extended-Release Tablets Read this Medication Guide before you start taking HORIZANT and each time
Intestinal Permeability Leaky Gut Syndrome Protocol Dr. Kurt Woeller, D.O.
Intestinal Permeability Leaky Gut Syndrome Protocol Dr. Kurt Woeller, D.O. Kurt N. Woeller, DO, is an osteopathic physician specializing in natural medicine. Dr. Woeller began his study of natural medicine
PACKAGE LEAFLET: INFORMATION FOR THE USER. Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide
PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide Read all of this leaflet carefully before you start using this medicine because it contains important
20150113 (NL/H/0795-809-810/001-002) FLECAINIDE ACETATE 100 MG; 50 MG TABLET 800-1126.00 800-1127.00. Package leaflet: Information for the user
Sandoz Business use only Page 1 of 6 Package leaflet: Information for the user [Nationally completed name] 50 and 100 mg tablets Flecainide acetate Read all of this leaflet carefully before you start taking
STRATTERA (Stra-TAIR-a)
1 PV 5859 AMP MEDICATION GUIDE STRATTERA (Stra-TAIR-a) (atomoxetine) Capsules Read the Medication Guide that comes with STRATTERA before you or your child starts taking it and each time you get a refill.
Package leaflet: Information for the patient. Co-amoxiclav 500 mg/125 mg Film-coated Tablets 500 mg/125 mg film-coated tablets
Package leaflet: Information for the patient Co-amoxiclav 500 mg/125 mg Film-coated Tablets 500 mg/125 mg film-coated tablets Amoxicillin Clavulanic acid Read all of this leaflet carefully before you start
Gabin 100mg, 300mg & 400mg Capsules GABAPENTIN
PACKAGE LEAFLET: INFORMATION FOR THE USER Gabin 100mg, 300mg & 400mg Capsules GABAPENTIN Read all of this leaflet carefully before you start taking this medicine because it contains important information
Package leaflet: Information for the patient. Desloratadine Actavis 5 mg orodispersible tablets desloratadine
Package leaflet: Information for the patient Desloratadine Actavis 5 mg orodispersible tablets desloratadine Read all of this leaflet carefully before you start taking this medicine because it contains
Salazopyrin Tablets. 500 mg. Sulfasalazine POM. 112 Tablets. Each tablet contains sulfasalazine 500 mg. Use as directed by a doctor. Oral use.
Salazopyrin Tablets 500 mg Sulfasalazine POM 112 Tablets Each tablet contains sulfasalazine 500 mg. Use as directed by a doctor. Oral use. Store below 25 C. Read the leaflet before use. Keep out of the
PRODUCT MONOGRAPH. Pr PROLOPA. levodopa and benserazide combination. Capsules 50-12.5, 100-25, 200-50. Pharmaceutical standard: professed
PRODUCT MONOGRAPH Pr PROLOPA levodopa and benserazide combination Capsules 50-12.5, 100-25, 200-50 Pharmaceutical standard: professed Antiparkinson Agent Hoffmann-La Roche Limited Date of Preparation:
Package leaflet: Information for the user
LOPID 300 mg hard capsules LOPID 600 mg film-coated tablets gemfibrozil Package leaflet: Information for the user Read all of this leaflet carefully before you start taking this medicine because it contains
SYNACTHEN DEPOT i.m. (tetracosactide hexaacetate) 1 mg/ml Suspension for injection
SYNACTHEN DEPOT i.m. (tetracosactide hexaacetate) 1 mg/ml Suspension for injection Consumer Medicine Information What is in this leaflet Read all of this leaflet carefully before you are given SYNACTHEN
Trileptal (Oxcarbazepine)
Brand and Generic Names: Trileptal Tablets: 150mg, 300mg, 600mg Liquid Suspension: 300mg/5mL Generic name: oxcarbazepine What is Trileptal and what does it treat? Trileptal (Oxcarbazepine) Oxcarbazepine
Package leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride
A leaflet will be included in each pack. The leaflet will consist of a Technical Information Leaflet and a Patient Information Leaflet. The two leaflets will be easily separatable. The text of the Technical
